gemtuzumab ozogamicin   Click here for help

GtoPdb Ligand ID: 6775

Synonyms: CDP 771 | CMA 676 | hP67.6-calicheamicin | Mylotarg® | WAY-CMA 676
Approved drug Immunopharmacology Ligand
gemtuzumab ozogamicin is an approved drug (FDA (2000), EMA (2018))
Compound class: Antibody
Comment: This drug is an antibody-drug conjugate (ADC) that targets delivery of the highly cytotoxic ozogamicin (a derivative of calicheamicin γ1) to CD33 +ve myeloid cells [1].
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (FDA (2000), EMA (2018))
International Nonproprietary Names Click here for help
INN number INN
10315 gemtuzumab ozogamicin
Synonyms Click here for help
CDP 771 | CMA 676 | hP67.6-calicheamicin | Mylotarg® | WAY-CMA 676
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 44
Other databases
GtoPdb PubChem SID 178103381
PubChem SID 178103381
Search PubMed clinical trials gemtuzumab ozogamicin
Search PubMed titles gemtuzumab ozogamicin
Search PubMed titles/abstracts gemtuzumab ozogamicin
Wikipedia Gemtuzumab_ozogamicin